Bruker Corp (BRKR) concluded trading on Thursday at a closing price of $36.69, with 3.62 million shares of worth about $132.76 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -35.23% during that period and on May 15, 2025 the price saw a loss of about -0.43%. Currently the company’s common shares owned by public are about 151.52M shares, out of which, 102.58M shares are available for trading.
Stock saw a price change of -9.43% in past 5 days and over the past one month there was a price change of -4.53%. Year-to-date (YTD), BRKR shares are showing a performance of -37.41% which decreased to -50.58% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $34.10 but also hit the highest price of $79.78 during that period. The average intraday trading volume for Bruker Corp shares is 2.43 million. The stock is currently trading -5.44% below its 20-day simple moving average (SMA20), while that difference is down -10.71% for SMA50 and it goes to -33.37% lower than SMA200.
Bruker Corp (NASDAQ: BRKR) currently have 151.52M outstanding shares and institutions hold larger chunk of about 81.40% of that.
The stock has a current market capitalization of $5.56B and its 3Y-monthly beta is at 1.16. PE ratio of stock for trailing 12 months is 69.87, while it has posted earnings per share of $0.53 in the same period. Its PEG reads 7.34 and has Quick Ratio of 0.74 while making debt-to-equity ratio of 1.16. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BRKR, volatility over the week remained 6.35% while standing at 4.75% over the month.
Stock’s fiscal year EPS is expected to rise by 0.93% while it is estimated to increase by 12.69% in next year. EPS is likely to grow at an annualized rate of 9.52% for next 5-years, compared to annual growth of -9.69% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Guggenheim on December 19, 2024 offering a Buy rating for the stock and assigned a target price of $72 to it. Coverage by UBS stated Bruker Corp (BRKR) stock as a Neutral in their note to investors on December 10, 2024, suggesting a price target of $66 for the stock. On December 05, 2024, Goldman Upgrade their recommendations, while on October 15, 2024, Barclays Initiated their ratings for the stock with a price target of $75. Stock get a Peer perform rating from Wolfe Research on September 30, 2024.
